Vantage Financial Partners (Wisconsin)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Vantage Financial Partners (Wisconsin)'s PFE Position: Q4 2025 in Review
Vantage Financial Partners (Wisconsin) increased its Pfizer (PFE) stake by 0.63% in Q4 2025, buying an estimated $1.56K and bringing the position to 9,942 shares worth $248K. The position accounts for 0.05% of the portfolio, ranked #183.
Vantage Financial Partners (Wisconsin) first reported a position in PFE in Q3 2024 and has held it in 4 quarters since. The position peaked at $268K in Q3 2024. 2,922 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Vantage Financial Partners (Wisconsin) held 9,942 shares of Pfizer worth $248K as of Q4 2025.
- Vantage Financial Partners (Wisconsin) bought 62 Pfizer shares in Q4 2025, an estimated $1.56K.
- Pfizer made up 0.05% of Vantage Financial Partners (Wisconsin)'s portfolio in Q4 2025, its #183 holding.
- Vantage Financial Partners (Wisconsin) first reported a position in Pfizer in Q3 2024 and has held it in 4 quarters since.
- Vantage Financial Partners (Wisconsin)'s Pfizer position peaked at $268K in Q3 2024.
- 2,922 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Vantage Financial Partners (Wisconsin)'s 13F filing for Q4 2025, filed 3 Feb 2026.